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and signaling molecules between these organelles. This is 
underscored by the fact that genes affecting mitochondrial 
and endoplasmic reticulum homeostasis are clearly over-
represented in several hereditary neurodegenerative dis-
orders. Conversely, the processes affected by the contact 
sites between the endoplasmic reticulum and mitochondria 
are widely implicated in neurodegeneration. This review 
will focus on the most recent data addressing the structural 
composition and function of the mitochondria-associated 
membranes. In addition, the 3D morphology of the con-
tact sites as observed using volume electron microscopy 
is discussed. Finally, it will highlight the role of several 
key proteins associated with these contact sites that are 
involved not only in dementias, amyotrophic lateral sclero-
sis and Parkinson’s disease, but also in axonopathies such 
as hereditary spastic paraplegia and Charcot–Marie–Tooth 
disease.
Abbreviations
AD  Alzheimer’s dementia
ALS  Amyotrophic lateral sclerosis
APP  Amyloid precursor protein
ATG  Autophagy-related
ATL1/3  Atlastin 1/3
CMT  Charcot–Marie–Tooth disease
CNX  Calnexin
DFCP1  Double FYVE-containing protein 1
DJ-1  Protein deglycase DJ-1
Drp1  Dynamin-related protein 1
EMC  Endoplasmic reticulum membrane complex
ER  Endoplasmic reticulum
ERMES  Endoplasmic reticulum-mitochondria encoun-
ter structure
FAD  Familial Alzheimer’s dementia
FIB-SEM  Focused ion beam scanning electron 
Abstract There is a growing appreciation that mem-
brane-bound organelles in eukaryotic cells communicate 
directly with one another through direct membrane contact 
sites. Mitochondria-associated membranes are special-
ized subdomains of the endoplasmic reticulum that func-
tion as membrane contact sites between the endoplasmic 
reticulum and mitochondria. These sites have emerged as 
major players in lipid metabolism and calcium signaling. 
More recently also autophagy and mitochondrial dynam-
ics have been found to be regulated at ER-mitochondria 
contact sites. Neurons critically depend on mitochondria-
associated membranes as a means to exchange metabolites 
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microscopy
Fis1  Fission 1 homolog
FTD  Frontotemporal dementia
GSK3β  Glycogen synthase kinase-3β
HSAN  Hereditary sensory and autonomous 
neuropathy
HSP  Hereditary spastic paraplegia
IMM  Inner mitochondrial membrane
INF2  Inverted formin 2
IP3R  Inositol 1,4,5-triphosphate receptor
MAM  Mitochondria-associated membrane
MCS  Membrane contact site
MCU  Mitochondrial calcium uniporter
Mff  Mitochondrial fission factor
MFN1/2  Mitofusin 1/2
miro1/2  Mitochondrial Rho GTPases 1/2
MT  Microtubule
OMM  Outer mitochondrial membrane
PA  Phosphatidic acid
PACS2  Phosphofurin acidic cluster sorting protein 2
PC  Phosphatidylcholine
PD  Parkinson’s disease
PE  Phosphatidylethanolamine
PEMT  Phosphatidylcholine-N-methyltransferase
PINK1  PTEN-induced putative kinase 1
PS1/2  Presenilin 1/2
PS  Phosphatidylserine
Pss1/2  Phosphatidylserine synthase 1/2
PTPIP51  Protein tyrosine phosphatase-interacting pro-
tein 51
REEP1/2  Receptor expression-enhancing protein 1/2
RTN2/4b  Reticulon 2/4b
RyR  Ryanodine receptor
SAD  Sporadic Alzheimer’s dementia
Sigma1R  Sigma non-opioid intracellular receptor 1
STX17  Syntaxin 17
TDP43  TAR DNA-binding protein 43
TEM  Transmission electron microscopy
Tom5  Outer mitochondrial membrane translocase 
complex 5
TRAK1/2  Trafficking kinesin protein 1/2
VAPB  Vesicle-associated membrane protein-associ-
ated protein B
VDAC1  Voltage-dependent anion channel 1
α-Syn  Alpha-synuclein
Mitochondria‑associated membranes are 
specialized subdomains of the ER
Compartmentalization of biochemical reactions to dedi-
cated membrane-bound organelles allows eukaryotic cells 
to perform the plethora of biological processes necessary 
to maintain homeostasis. While this has clear advantages, 
it also requires transfer of metabolites and signaling mol-
ecules between organelles to maintain cell performance. 
Such inter-organelle communication is often achieved via 
vesicular transport or transcriptional pathways. In recent 
years, alternative pathways involving direct communica-
tion between organelles through membrane contact sites 
(MCSs) have gained much interest. At MCSs, the mem-
branes of two organelles are closely apposed through the 
formation of protein tethers, enabling fast, direct and recip-
rocal signaling between both compartments. With distances 
between the tip of the axon and the cell body reaching up 
to one meter in humans, the particular morphology of neu-
rons poses limits on vesicular transport and transcriptional 
pathways. Processes that require strict regulation in space 
and time are therefore likely to depend much more on such 
MCSs. We focus this review on the contact sites that are 
formed between mitochondria and a specialized subdomain 
of the endoplasmic reticulum (ER) termed Mitochondria-
Associated Membranes (MAMs). Emerging evidence 
shows that dysfunction of the MAMs plays a prominent 
role in numerous neurodegenerative diseases and that genes 
affecting ER and mitochondrial homeostasis are clearly 
overrepresented in hereditary disorders.
Close membrane appositions between the ER and mito-
chondria have been observed in electron micrographs as 
early as the 1950s [10, 24]. The ongoing development of 
subcellular fragmentation techniques repeatedly showed 
a resilient ER contamination in mitochondrial fractions, 
substantiating the existence of MCSs between the ER 
and mitochondria. Only in 1990, with the description of a 
membrane fraction ‘X’ associated with mitochondria and 
involved in phospholipid synthesis, the first function for 
this interface was identified [110]. This fraction ‘X’, now 
commonly referred to as the MAMs, is a specialized sub-
domain of the ER with a particular lipid and protein com-
position that is involved in the crosstalk with mitochondria. 
These ER-mitochondria contacts have since then been 
described in several organisms ranging from yeast to mam-
mals [109]. Approximately 100 of such contacts are shown 
to occur in a single yeast cell and in mammalia approxi-
mately 5–20 % of the mitochondrial surface is estimated 
to be juxtaposed to the ER [1, 88]. Despite the ongoing 
development of superresolution techniques, the resolu-
tion of light microscopy is too limited for precise analysis 
of the morphology of ER-mitochondria contact sites, with 
the distance between both membranes at these sites being 
10–30 nm. Transmission electron microscopy (TEM) does 
provide the required resolution; however, even when using 
tomography, it is very limited in the amount of 3D infor-
mation which can be acquired. Volume electron micros-
copy techniques such as focused ion beam scanning elec-
tron microscopy (FIB-SEM) recently became available to 
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obtain high-resolution 3D images of a whole cell and can 
thus be used as a powerful tool to gain more insight into 
the 3D morphology of MAMs [59]. Figure 1 and Supple-
mentary movie 1 show the 3D reconstruction of mitochon-
dria and their associated MAMs obtained using FIB-SEM 
imaging of a mouse embryonic fibroblast. These images 
clearly show that each mitochondrion makes multiple con-
tacts with the ER and that all these contact sites are highly 
diverse in shape and size. It is currently unknown how 
MAM morphology relates to its function and therefore vol-
ume electron microscopy will be a crucial tool in studying 
the role different proteins play in regulating these contact 
sites.
Historically, the ER-mitochondria MCSs have been 
associated with phospholipid exchange between the ER 
and mitochondria [88]. In addition, the close proximity 
between both membranes appears to be critical for the 
efficient transfer of calcium from the ER to mitochondria. 
Further studies have revealed additional roles for ER-
mitochondria MCSs in a variety of processes ranging from 
mitochondrial dynamics, sterol metabolism, autophagy, 
cell survival to energy metabolism and protein folding. 
Concomitant with the growing appreciation of this signal-
ing hub, the list of disorders associated with ER-mitochon-
dria MCSs is extending. To date this includes cancer [108], 
metabolic disorders such as Wolfram syndrome [114] or 
GM1-gangliosidosis [91], diabetes [104], viral infection 
[48], obesity [7], and neurodegeneration (see Table 1; 
Boxes 1–4).
Several observations indicate that mitochondria-ER 
contact sites play crucial roles in neuronal survival and 
death. Mitochondria in contact with the ER can be read-
ily observed in brain tissue, throughout neurons and at 
synapses [47]. Already in 2002, it has been suggested 
that the choreographed interplay between the ER and 
mitochondria is involved in the shaping of dendritic 
calcium signals and neuronal activity of hippocampal 
neurons [84]. In addition at the synapse, calcium shut-
tling between both compartments was suggested to be 
essential in determining exocytosis and synaptic activ-
ity [74]. The involvement of signaling at the MAMs is 
implied in several neurodegenerative disorders including 
Alzheimer’s dementia (AD) [93], Amyotrophic Lateral 
Sclerosis (ALS) and Frontotemporal Dementia (FTD) 
[9, 85, 97], Parkinson’s Disease (PD) [17, 42, 82] and 
Charcot–Marie–Tooth disease (CMT) [28] (for a compre-
hensive overview see Table 1; Boxes 1–4). More gener-
ally, many if not all processes linked to ER-mitochondria 
contacts are widely implied in neurodegenerative disor-
ders. This review will focus on the structure and func-
tion of MAMs and how their disruption contributes to 
neurodegeneration.
Structural composition of the MAMs
The MAM fraction can be detached from mitochondria 
through proteolysis with trypsin or Proteinase K, show-
ing that a proteinaceous tether is responsible for connect-
ing both membranes [26]. The presence of such a protein 
bridge has been confirmed in electron microscopy studies 
[26, 97], but despite this, the identity of its components still 
remains largely elusive. Most proteins that have been found 
to be enriched at the MAMs, are unlikely to participate 
directly in tethering, but might be functionally involved in 
the processes mediated by these contacts [108, 109].
In yeast, genetic screens independently led to the discov-
ery of the ER-Mitochondria Encounter Structure (ERMES) 
complex [55] and the ER membrane protein complex 
(EMC) [60] as functional tethers between the ER and mito-
chondria (see Fig. 2 lower part). The ERMES complex 
consists of the outer mitochondrial membrane proteins 
Mdm10 and Mdm34, the ER membrane protein Mmm1 
and the cytosolic Mdm12. Loss of any of these proteins 
could be rescued by the expression of an artificial linker, 
establishing the structural role of ERMES. Gem1, the yeast 
ortholog of the mitochondrial Rho GTPases 1 and 2 (Miro1 
and Miro2), and more recently also Lam6, were identi-
fied as regulators of the ERMES complex [32, 56, 78]. A 
second screen identified the interaction between the EMC 
and the outer mitochondrial membrane (OMM) translocase 
complex 5 (Tom5) as an interaction bridging the ER and 
mitochondrial membranes independent of ERMES (Fig. 2 
lower part). In contrast to the ERMES complex, this con-
tact is essential in the lipid exchange between both orga-
nelles [60]. While Lam6, Gem1 and the EMC proteins do 
have metazoan orthologs, it is as yet unclear whether these 
orthologs effectively function as regulators of interorga-
nelle contact in mammalia.
The first complex identified in mammalian cells that 
bridges the gap between the MAM and the OMM is 
the tripartite complex between the cytosolic chaperone 
Grp75, the mitochondrial voltage-dependent anion chan-
nel 1 (VDAC1) and the inositol 1,4,5-triphosphate receptor 
(IP3R) in the MAM [100] (Fig. 2 upper part). While knock-
down of Grp75 in HeLa cells decreases the transfer of cal-
cium from the ER to mitochondria, ER-mitochondrial link-
age is unaffected in cells lacking all three IP3R isoforms 
[26]. Therefore, rather than representing a structural tether, 
this interaction is considered a functional one, promoting 
efficient transfer of calcium from the ER to mitochondria 
(see below). Other candidate protein tethers are the homodi-
mers or heterodimers of ER-resident Mitofusin (MFN) 2, 
a dynamin-related GTPase, with MFN1 or MFN2 on the 
OMM (Fig. 2 upper part) [28]. Cells depleted of MFN2 
were reported to have decreased ER-mitochondria contact 
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Fig. 1  3D morphology of 
ER-mitochondria contact sites. 
Mouse embryonic fibroblasts 
were imaged using a Zeiss 
Auriga Crossbeam focused ion 
beam scanning electron micro-
scope (FIB-SEM). By auto-
mated serial block face imaging, 
large image stacks are generated 
at high resolution, allowing 
precise 3D reconstruction of a 
large cellular volume. In this 
dataset, over 600 10 nm z-slices 
were obtained resulting in a 
3D dataset at 5 × 5 × 10 nm3 
voxels. Mitochondria and their 
contact sites with the endo-
plasmic reticulum (ER) were 
manually segmented and 3D 
reconstructed in IMOD (http://
bio3d.colorado.edu/imod/). A 
video of this dataset and the 
reconstruction can be seen in 
Supplementary movie 1. a The 
complete reconstruction of 
two mitochondria (transparent 
green) and their ER-mitochon-
dria contact sites (magenta) is 
shown. A contact site is defined 
as a region where the ER and 
the mitochondrial membranes 
are in closer proximity than 
30 nm. It is clear that a single 
mitochondrion makes multiple 
contacts with the ER and that 
these contacts are diverse in 
size, ranging from punctate 
sites to large patches of the 
outer mitochondrial membrane 
being juxtaposed to the ER. b–e 
Represent different examples of 
scanning electron micrographs 
extracted from the volume 
illustrating a section of the 
mitochondria and their contacts 
with the ER. The reconstructed 
mitochondria depicted in a are 
shown in transparent green. 
Magenta arrowheads mark the 
borders of the ER-mitochondria 
contact sites. The position of 
these slices is depicted in blue 
in a. Scale bar 200 nm
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Table 1  Overview of the 
genes affected in distinct 
neurodegenerative diseases and 
associated with MAM functions 
and/or structure
Disorder Full name Abbreviation Function at ER-mitochondria MCSs Links to the disorder References
Alzheimer's Dementia Amyloid precursor protein APP APP is enriched at the MAM, though its function there is 
unclear. Mutations in APP induce upregulated ER-
mitochondria contact in the brain. APP processing by the γ-
secretase depends on IP3R-dependent calcium release and is 
downregulated upon loss of MFN2, a proposed tether of ER-
mitochondria MCSs. 
Mutations in APP cause FAD and defective APP 
processing, which results in the formation of amyloid 
plaques, is a major hallmark of both FAD and SAD.
[5, 6, 47]
Apolipoprotein E, allele ε4 ApoE4 No function at the MAM is reported. Astrocytes treated with 
ApoE4 containing medium were found to have upregulated 
MAM lipid metabolism, including increased PE and 
cholesteryl ester synthesis.
The ApoE4 allele is the best known risk factor 
contributing to the development of SAD
[101]
Glycogen synthase kinase 3β GSK3β A protein kinase that negatively regulates ER-mitochondria 
MCS formation, through the modulation of the VAPB-
PTPIP51 interaction.
GSK3β is a cardinal regulator of numerous signaling 
pathways in the brain. Its dysregulation has been 
proposed to be involved in amyloid and tau pathology, 
but also other contributors to the AD phenotype such as 
neuroinflammation.
[66, 97]
Phosphofurin acidic cluster 
sorting protein 2
PACS2 PACS2 promotes ER-mitochondrial contact through an 
unknown mechanism. At the MAMs, it is required for proper 
autophagosome biogenesis. In addition, it targets calnexin to 
the MAMs, thereby influencing calcium handling at this 
interface.
PACS2 is found upregulated in the post-mortem brains 
of AD patients as well as in an AD mouse model. This 
upregulation could underlie the higher extent of ER-
mitochondrial contact observed in these brains.
[4, 47, 79]
Presenilin 1 & 2 PS1 & PS2 Components of the γ-secretase complex involved in APP 
processing. γ-secretase and activity thereof is enriched at the 
MAM and requires intact ER-mitochondrial communication. 
Loss or mutation of PS1 and PS2 results in augmented ER-
mitochondrial contact and lipid transfer. PS1 and PS2 bind 
IP3Rs and FAD-causing mutations result in excess calcium 
release from the ER.
Mutations in PS1 and PS2, like those in APP, cause 
familial AD characterized by an early-onset of the 
disease phenotype.
[5, 6, 22]
Sigma non-opioid intracellular 
receptor 1
Sigma1R A modulator of calcium signaling at the MAM. Sigma1R 
stabilizes IP3R, resulting in sustained calcium release. 
Targetting of Sigma1R to the MAM depends on the lipid 
composition of the MAMs. Sigma1R-deficient mice show 
reduced ER-mitochondria MCSs, an upregulated unfolded 
protein response and disturbed calcium homeostasis and 
mitochondrial dynamics.
Like PACS2, Sigma1R was found upregulated in post-
mortem AD brain in humans. In contrast, it was 
downregulated in the brain of an AD mouse model.
[45-47]
ALS and FTD-ALS Glycogen synthase kinase 3β GSK3β (see above) TDP43, accumulation of which is widely implied in the 
pathogenesis of ALS and FTD, acts upstream of 
GSK3β. Overexpression of TDP43 reduces the 
inhibitory phosphorylation of GSK3β, thus resulting in 
overactivation of this kinase.
[97]
Sigma non-opioid intracellular 
receptor 1
Sigma1R (see above) Mutations in this gene and in its 3'UTR were identified 
in juvenile-onset ALS and FTD-ALS patients and 
Sigma1R could be detected in TDP43-positive 
inclusions. Mice deficient of Sigma1R mimic a motor 
neuron disease phenotype.
[2, 9, 67]
TAR DNA-binding protein 43 TDP43 Acts upstream of GSK3β. Overexpression of TDP43 
increases GSK3β activity and thus weakens ER-mitochondrial 
connectivity.
TDP43 positive inclusions are a hallmark of FTD and 
ALS, and have also been found in patients with AD and 
PD. Mutations in TDP43 account for 3% of familial ALS 
and 1.5% of sporadic ALS cases.
[63, 97]
VAMP (vesicle-associated 
membrane protein)-associated 
binding protein B and C
VAPB VAPB establishes a protein tether through its interaction with 
PTPIP51 on the OMM. This tether is modulated by GSK3β 
activity, which in turn depends on TDP43 levels. Expression 
of VAPB P56S increases the PTPIP51-dependent connection 
between the ER and mitochondria.
The VAPB P56S mutation causes a very severe type of 
ALS known as familial ALS type 8.
[29, 81, 97]
Parkinson's Disease Alpha-synuclein α-Syn Overexpression of α-Syn promotes crosstalk between the ER 
and mitochondria, whereas loss of α-Syn has the opposite 
effect. Like Parkin and DJ-1, α-Syn is thought to interact with 
the MAM-associated cytosolic chaperone Grp75, though no 
function is known for this interaction.
Lewy bodies, a hallmark of PD pathology, are protein 
accumulations largely consisting of aggregated α-Syn. 
Mutations in α-Syn are resonsible for familial PD.
[17, 42, 94]
Glycogen synthase kinase 3β GSK3β (see above) GSK3β plays roles in numerous processes that 
contribute to neurodegeneration. It has been found 
overexpressed and overactivated in post-mortem PD 
brains. Along with α-Syn, GSK3β has been found in 
Lewy bodies and overexpression of α-Syn in mice was 
shown to induce GSK3β activation.
[41]
Parkin Parkin Overexpression of Parkin increases the physical and 
functional coupling of ER and mitochondria, through an 
unknown mechanism. Parkin interacts with two MAM-
associated proteins: Grp75 and MFN2. Ubiquitination of 
MFN2 by Parkin plays a role in mitochondrial dynamics and 
mitophagy, two process controlled at ER-mitochondria MCSs. 
Mutations in the PARK2 gene encoding Parkin cause 
familial PD.
[18, 51, 94, 
102]
Protein deglycase DJ-1 DJ-1 DJ-1 overexpression enhances ER-mitochondrial coupling. It 
interacts with Grp75, a cytosolic chaperone linking IP3Rs to 
VDAC to promote efficient calcium transfer from the MAM to 
its apposed mitochondria.
Mutations in PARK7, encoding DJ-1, cause familial PD. [82, 94]
PTEN-induced putative kinase 
1
PINK1 PINK1 recruits Parkin to the OMM, where Parkin ubiquitinates 
substrates that include MFN2, involved in mitophagy and 
regulating mitochondrial dynamics.
Causative mutations for familial PD have been identified 
in the gene encoding PINK1.
[94, 102]
Inherited Peripheral 
Neuropathies
Atlastin 1 & 3 ATL1 & ATL3 ATL1 and ATL3 mediate homotypic ER membrane fusion. No 
direct role at the MAM has been described, however it was 
shown that HSP-causing mutations in ATL1 affect 
mitochondrial distribution within axons, suggesting that these 
proteins may have an (indirect) effect on ER-mitochondrial 
communication.
Mutations in ATL1 and ATL3 were identified in HSAN 
patients. This inherited peripheral neuropathy subtype is 
characterized by the predominant involvement of the 
sensory and autonomous nerves, with little or no 
involvement of motor functions.
[49, 54, 116]
Inverted Formin 2 INF2 INF2 is involved in actin remodelling. ER-bound INF2 
localizes to MAMs, where it contributes to mitochondrial 
fission by promoting mitochondrial constriction prior to Drp1 
assembly.
Heterozygous mutations in the gene encoding INF2 are 
associated with CMT type 2D, complicated with 
glomerulopathy.
[15, 57, 58]
Mitofusin 2 MFN2 MFN2 was the first proposed protein tether connecting the ER 
and mitochondria at the MCS in mammalia. Though its 
structural role at MAMs is controversial, loss of MFN2 was 
found to affect MAM functions including calcium signaling, 
lipid metabolism, autophagy induction and mitochondrial 
dynamics in several independent studies.
Mutations in MFN2 are the most common cause of 
axonal CMT, also known as CMT type 2.
[4, 5, 28, 75]
Receptor expression-enhancing 
protein 1
REEP1 The REEP protein family members introduce positive 
membrane curvature in the ER membrane through insertion 
of hairpin loops, similar to RTNs. Using a split-luciferase 
assay, overexpression of WT REEP1 was found to promote 
contact site formation, a trait that was lost in HSP-causing 
mutant forms of REEP1. As REEP1 was also reported to 
localize to mitochondria, this protein might play a direct role in 
MCS assembly, though further research is required to study 
the exact role, direct or indirect, REEP1 plays at the MAMs.
Mutations in REEP1 underlie an inherited peripheral 
neuropathy termed distal hereditary motor neuropathy 
type 5B, characterized by muscle weakness and 
atrophy, primarily in the hands but also affecting the 
lower legs.
[49, 64]
Hereditary Spastic 
Paraplegia
Atlastin 1 ATL1 (see above) Mutations in ATL1 cause an autosomal dominant pure 
form of HSP known as spastic paraplegia (SPG) type 
3A. This subtype is futher characterized by an early age 
of onset.
[49, 116]
Mitochondrial Rho GTPase 1 Miro1 The yeast ortholog of Miro1 is a regulator of the ERMES 
tethering complex. In higher eukaryotes, no structural role for 
Miro1 at the MAM has been described. Several observations 
however indicate that such a role exists. Not in the least, the 
requirement of high calcium concentrations such as those 
found at the ER-mitochondrial MCS of Miro1-dependent 
mitochondrial transport regulation point to such a role.
No mutations have been found in patients thus far, 
however a mouse model deficient of Miro1 displays a 
spastic paraplegia-like phenotype. 
[20, 56, 92]
Receptor expression-enhancing 
protein 1 & 2
REEP1 & REEP2 (see above) Mutations in these genes cause autosomal dominant 
(REEP1 & REEP2) or autosomal recessive (REEP2) 
HSP.
[49]
Reticulon 2 RTN2 Like the REEPs, RTNs induce membrane curvature through 
its specific hairpin topology. RTN4b, a close homolog of 
RTN2, was reported as a negative regulator of ER-
mitochondrial contact and crosstalk in the lungs. Because of 
the high evolutionary conservation, it is not unlikely that the 
other RTNs including RTN2 could play a similar role.
RTN2 mutations were identified in patients diagnozed 
with SPG12, an autosomal dominant disorder 
characterized by lower limb spasticity and hyperreflexia 
resulting in spastic gait.
[49, 99]
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and crosstalk [5, 28, 44, 82]. CMT-causing mutations in 
MFN2 failed to rescue the disrupted ER-mitochondria teth-
ering (see Box 4; Table 1) [28]. MFN2 dependent ER-mito-
chondria crosstalk is tightly controlled by ubiquitination, 
further supporting its essential role [98]. Still, independent 
studies could not confirm the crosstalk-promoting role of 
MFN2 in ER-mitochondria contacts, but rather reported the 
opposite finding, i.e., loss of MFN2 led to an increase in 
MCS [25, 34]. These contradictory findings remain to be 
resolved, as does the effect of CMT-causing mutations in 
MFN2 on MAM signaling (see Table 1; Box 4).
Adding to this complexity, additional tethering interac-
tions have been identified, which might compensate for 
MFN2 loss in certain conditions. One such tether is the 
physical interaction between the MAM protein VAMP 
(vesicle-associated membrane protein)-associated pro-
tein B and C (VAPB) and the mitochondrial protein tyros-
ine phosphatase-interacting protein 51 (PTPIP51) (Fig. 2 
upper part) [29, 97]. Overexpression of either or both of 
these proteins increases the extent of contact while loss of 
either protein through siRNA-mediated knockdown signifi-
cantly diminishes membrane contact and crosstalk [97]. A 
functional rather than a structural interaction between the 
ER and mitochondria has been uncovered by establishing 
the interaction between ER-resident BAP31 and the mito-
chondrial fission protein Fission 1 homolog (Fis1) [50]. 
The complex formed between BAP31/Fis1 constitutes an 
apoptosis-signaling platform needed for the recruitment 
of procaspase 8, the cleavage of BAP31 and a subsequent 
increase in Ca2+ release from the ER to the mitochondria 
MFN1/2
MFN2 PACS2
Grp75
IP3R
VDAC
GSK3β
TDP43
ER
Cytosol
Cytosol
ERMES Mdm34
Mdm10
Mmm12
Mmm1
ER
Lam6
Gem1
EMC
complex
TOM5
mammals
yeast
PTPIP51
VAPB
OMM
Ca²⁺
Fig. 2  Structural components of ER-mitochondria contact sites. 
Upper part in mammalian cells, dimers between endoplasmic reticu-
lum (ER)-localized Mitofusin (MFN) 2 and mitochondrial MFN1/2 
were the first proposed protein tethers. Charcot–Marie–Tooth 
(CMT)-causing mutations in MFN2 are believed to decrease ER-
mitochondrial contact, contributing to the disease. The interaction of 
VAMP-associated protein B and C (VAPB) in the ER membrane with 
protein tyrosine phosphatase-interacting protein 51 (PTPIP51) in the 
outer mitochondrial membrane (OMM) also contributes to anchor-
ing the mitochondria-associated membrane (MAM) to the mitochon-
drial membrane. This interaction is inhibited by TAR DNA-binding 
protein 43 (TDP43) in a glycogen synthase kinase 3β (GSK3β) 
dependent manner. Both these proteins are implied in neurodegen-
eration (see Table 1; Boxes 1, 2). The amyotrophic lateral sclerosis 
(ALS)-causing P56S mutation in VAPB on the other hand increases 
the physical interaction between the ER and mitochondria (Table 1; 
Box 2). Phosphofurin acidic cluster protein 2 (PACS2) is established 
as an essential component of these contacts. The levels of PACS2 
are found to be altered in the brains of Alzheimer’s dementia (AD) 
patients (see Table 1; and Box 1). A functional rather than a struc-
tural component of the MAMs is formed by a complex between ER-
resident inositol 1,4,5-triphosphate (IP3) channels and the mitochon-
dria resident voltage-dependent anion channel (VDAC), which are 
bridged by Grp75 and important for calcium shuttling between ER 
and mitochondria (see Fig. 3). Lower part in Saccharomyces cerevi-
siae, two tethering complexes are known: the endoplasmic reticulum 
(ER) mitochondria encounter structure (ERMES), composed of the 
mitochondrial Mdm10 and Mdm34 proteins, the ER-based Mmm1 
protein and the cytosolic Mdm12 protein was the first tether to be 
described. A second tether important for yeast phospholipid metabo-
lism is achieved through the interaction between the ER membrane 
complex (EMC) and the outer mitochondrial membrane translocate 
complex 5 (TOM5). The Miro GTPase Gem1 is a regulatory subunit 
of ERMES and also Lam6 plays a modulating role determining the 
extent of membrane contact. It is currently not known whether mam-
malian orthologs of these components play similar roles in mamma-
lian MAMs
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[50]. This fits with earlier notions that a feedback ER con-
tribution is needed to amplify mitochondrial apoptosis sig-
nals [3]. Finally, the vesicular sorting protein phosphofurin 
acidic cluster sorting protein 2 (PACS2) contributes to the 
structural integrity of the ER-mitochondria MCSs, through 
a stabilization mechanism that is not entirely clear [95] 
(Fig. 2 upper part). The siRNA-mediated knockdown of 
PACS2 uncouples the ER from mitochondria and induces 
BAP31 cleavage-dependent mitochondrial fragmentation 
and cell death in A7 melanoma cells [95], and similarly 
results in caspase-3 mediated degeneration of primary hip-
pocampal neurons and astrocytes [47]. The complex role 
of PACS2 as a modulator of MAM properties is discussed 
further.
Although the mediators of these MCSs seem to be quite 
distinct between yeast and mammals, the property that dif-
ferent and independent linkers are involved in the coupling 
of both membranes is conserved. The relevance of having 
diverse connections is currently unclear, however, it does 
suggest that these could serve distinct functions. A recent 
study in mammalian cells indeed indicates the presence of 
two distinct domains in MAMs that differ in their lipid con-
tent and function [4], yet more research is needed to shed 
light on how distinct protein and lipid compositions can 
affect MAM function.
Several essential cellular processes are controlled 
by MAMs
As stated in the introduction, recent studies revealed sev-
eral novel functions for the MAMs. In the following sec-
tions we will give a brief description of the most important 
MAM functions in the context of neurobiology.
Regulation of lipid metabolism
Although most membrane lipid synthesis in eukaryotic 
cells occurs in the ER, several key metabolic steps and 
lipid modifications are performed in other organelles, and 
thus, require transport of lipids. How hydrophobic lipids 
are distributed within the aqueous environment of the 
cell towards other organelles remains largely elusive, but 
recently the role of non-vesicular transport at membrane 
contact sites has gained a lot of interest [61, 109]. Close 
membrane apposition at these sites appears to allow effi-
cient shuttling of lipids. In addition, several lipid meta-
bolic enzymes are exclusively localized at certain MCSs, 
restricting the generation of these lipid species to the site 
where they are needed. MAMs were originally identified as 
a fraction highly enriched in phosphatidylserine (PS) syn-
thase-1 and -2 (Pss1 and Pss2) and transfer of phospholip-
ids between the ER and mitochondria was the first function 
ascribed to ER-mitochondria contacts [109]. Phosphati-
dylserine, newly synthesized in the MAM by the PS syn-
thases, is subsequently transferred to the closely apposed 
mitochondrion (Fig. 3). In the inner mitochondrial mem-
brane (IMM), decarboxylation of PS results in the produc-
tion of phosphatidylethanolamine (PE). The importance of 
ER-mitochondria MCSs is underlined by the fact that the 
transfer of PS between both organelles is the rate-limiting 
step in PE synthesis from PS [112]. In a crude mitochon-
drial fraction derived from rat liver, newly synthesized 
PE can then be transferred back to the MAM where it is 
converted into phosphatidylcholine (PC) by the enzyme 
PE-N-methyltransferase (PEMT) [110]. Since PEMT activ-
ity is restricted to hepatocytes, it is not clear how essential 
MAMs are for PC synthesis in other tissues.
Protein identification approaches revealed that not only 
Pss1 and Pss2 are enriched at the MAMs, but also several 
other lipid synthesizing enzymes involved in cholesterol 
and sphingolipid biosynthesis (Fig. 3) [39, 45, 109]. This 
fits well with thin layer chromatography studies showing 
that MAMs comprise a unique lipid profile, with highly ele-
vated levels of ceramides and cholesterol compared to the 
bulk ER [45]. While it is yet unclear whether the MAMs 
participate in trafficking of these lipids to mitochondria, 
this particular lipid raft-like composition plays a determin-
ing factor in the recruitment of several well-established 
MAM components. Both presenilin 1 and 2 (PS1 and PS2), 
members of the γ-secretase complex are targeted to the 
MAMs because of their lipid raft composition [106]. Simi-
larly, the chaperone Sigma non-opioid intracellular receptor 
1 (Sigma1R), associated with AD, ALS and FTD is strictly 
dependent on the presence of cholesterol and ceramide for 
targeting to the MAMs [45] and for performing its essential 
functions in calcium regulation (see Table 1; Fig. 4).
Regulation of calcium homeostasis at the MAMs
Already in the 19th century, the role of calcium as second 
messenger was established through seminal experiments on 
perfusion of isolated hearts. Since then, a lot of research has 
been devoted to understand how increases in calcium levels 
(so-called oscillations) are generated, decoded and trans-
lated in signaling events. Two major sources count for the 
rise in cytosolic calcium: the extracellular medium with a 
[Ca2+] of ~1 mM and the ER with a [Ca2+] >100 μM [87]. 
Mitochondria play a crucial role in buffering increases in 
cytosolic calcium, and a rise in cytosolic [Ca2+]cyt is always 
closely followed by a rise in [Ca2+]mito [89]. Interestingly, 
upon ER calcium release, mitochondrial levels can rapidly 
increase 10–100-fold without noticeable rises of cytosolic 
calcium levels [87]. In contrast to the outer mitochondrial 
membrane (OMM), which is permeable to calcium ions, 
influx of calcium into the mitochondrial matrix—driven 
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by the electrical gradient across the IMM—occurs through 
the recently identified mitochondrial calcium uniporter 
(MCU) complex. This complex consists of the MCU pro-
tein and its regulators (MICU1, MICU2, MCUb, MCUR1, 
and EMRE) [72]. Paradoxically, the low calcium affinity 
of the MCU appears incompatible with the observed rapid 
calcium uptake in mitochondria at low cytosolic calcium 
levels. This discrepancy was solved by the observation that 
mitochondria are in close contact with the IP3Rs and ryan-
odine sensitive channels (RyRs) mediating ER store release 
[88]. This occurs at the MAMs and leads to the transient 
formation of “hotspots”, perimitochondrial microdomains 
in which calcium levels far exceed those in the bulk of the 
cytosol, enabling rapid import across the IMM [27, 40, 88].
ER-mitochondria MCSs are able to establish such micro-
domains required for efficient calcium transfer through (1) 
the close apposition of both membranes, (2) the enrich-
ment of the calcium release channels IP3Rs and RyRs at 
MAMs and (3) the connection of IP3Rs to the mitochon-
drial VDAC1 by the chaperone Grp75 (Fig. 4). Knockdown 
of Grp75 abolishes functional coupling between VDAC1 
and IP3R, resulting in diminished calcium transfer [100]. 
On the other hand, bringing the ER closer to mitochondria 
through an artificial linker stimulates calcium transfer [26]. 
Numerous studies have correlated altered ER-mitochon-
drial connectivity to alterations in calcium transfer between 
both organelles, through overexpression or knockdown of 
proposed tethers, including MFN2 and VAPB-PTPIP51, or 
regulators thereof [28, 29, 34, 97] (Fig. 4). Several modu-
lators of IP3R channel activity are present at or recruited 
to MAMs under various conditions. For example, various 
ER-resident chaperones and oxidoreductases can affect 
the exchange of calcium between the ER and mitochon-
dria [96]. Calnexin (CNX) modulates local calcium lev-
els by acting as a calcium buffer and through regulating 
the activity of IP3R and the sarco/endoplasmic reticulum 
calcium ATPase (Serca), the main ATPase pumping cyto-
solic calcium into the ER [52, 68, 90]. CNX targeting to 
the MAM is dependent on palmitoylation [68], and on the 
cytosolic sorting protein PACS2 [79] and Rab32 [16] two 
trafficking molecules that both regulate the composition of 
the MAMs (Fig. 4). The ER-resident Sigma1R is released 
from Bip upon ER calcium release, and binds to IP3Rs at 
the MAMs, in this way preventing their proteasomal degra-
dation and sustaining prolonged Ca2+ uptake by mitochon-
dria [46] (Fig. 4). Especially in neurons, both Sigma1R and 
PACS2 play a crucial role in mediating calcium homeosta-
sis and loss of Sigma1R results in neuromuscular defects 
[47]. This is underscored by the fact that alterations in 
PACS2 and Sigma1R levels are associated with the patho-
genesis of AD, ALS and FTD (see Table 1; Boxes 1, 2). In 
addition, presenilin mutations in AD are associated with 
an increased IP3R calcium release (see Table 1; Box 1). 
Finally, in Huntington’s disease ER-mitochondrial calcium 
transfer appears affected as well. Mutant huntingtin, but not 
the wild type protein, was found to interact with IP3R and 
PA
Pss1/2 Pemt
Psd
PS
PS PE
PE PC CHOL
CHOL Sterols
ER
Cytosol
OMM
IMM
Fig. 3  Lipid metabolism at MAMs. Historically, MAMs were identi-
fied as essential regions for phospholipid metabolism. For phosphati-
dylethanolamine (PE) synthesis, phosphatidylserine (PS) synthesized 
in the endoplasmic reticulum (ER) from phosphatidic acid (PA) by 
the PS synthetases 1 and 2 (Pss1/2) needs to be shuttled to the inner 
mitochondrial membrane (IMM), where it is decarboxylated to PE 
by the PS decarboxylase (Psd). This PE can then be shuttled back to 
the ER and used in further lipid metabolism, such as conversion to 
phosphatidylcholine (PC) by the PE-N-methyltransferase (PEMT). 
In addition, the synthesis of sterols requires the import of cholesterol 
(chol) from the ER into mitochondria
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facilitate calcium transfer between the ER and mitochon-
dria [12, 83].
Calcium transfer to mitochondria occurs under both 
physiological and stress conditions. A moderate mito-
chondrial matrix calcium increase stimulates ATP synthe-
sis through calcium dependency of metabolic enzymes in 
the Krebs cycle [87]. Functional coupling of the ER and 
mitochondria therefore stimulates aerobic metabolism, in 
response to a demand of ATP-requiring processes in the 
cytosol as well as in the ER [96, 111]. Hence, loss of con-
tact has adverse effects on ER homeostasis, protein fold-
ing and energy metabolism [14], and will affect cell sur-
vival and proliferation, especially in cells with high-energy 
demands such as neurons. Mitochondrial calcium overload 
on the other hand is a potent inducer of the mitochondrial 
permeability transition pore and can thereby lead to OMM 
rupture and the escape of pro-apoptotic factors such as 
cytochrome c into the cytosol [87]. In this respect, regula-
tion of ER-mitochondrial calcium transfer at the MAMs 
is essential in the switch between cell survival and death 
during various stress responses. In the context of Hunting-
ton’s disease for example, the binding of mutant huntingtin 
to IP3R may result in a heightened susceptibility of mito-
chondria to activate the permeability transition pore and the 
subsequent release of pro-apoptotic factors [23]. Intrigu-
ingly, proteins that modulate calcium transfer between 
mitochondria and the ER are affected in many neurodegen-
erative diseases and could be tightly linked to a loss in neu-
ronal survival [94] (see Table 1).
Regulation of mitochondrial dynamics and homeostasis
The function of both the ER and mitochondria strongly 
depends on a highly regulated balance in membrane 
dynamics. Mitochondrial dynamics include their transport 
along cytoskeletal tracks throughout the cell, in addition 
to regulated fission and fusion. Combined, these dynamics 
ensure optimal mitochondrial metabolism and, in neurons, 
the correct distribution of mitochondria to dendrites and 
synapses. Especially in neurons with long axons this poses 
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Fig. 4  Calcium signaling at ER-mitochondria membrane contact 
sites. Transfer of calcium to mitochondria requires calcium hot-
spots, which can be achieved at mitochondria-associated membranes 
(MAMs) owing to the quasi-synaptic structure of this membrane 
contact site (MCS). Shuttling of calcium is needed during a variety 
of responses, as it can both stimulate ATP synthesis and promote 
mitophagy and apoptosis. Efficient import of calcium at MAMs 
is mediated by Grp75, which brings the openings of the inositol 
1,4,5-triphosphate receptor (IP3R) calcium channels in the endoplas-
mic reticulum (ER) in close vicinity to the voltage dependent anion 
channel (VDAC) in the outer mitochondrial membrane (OMM). 
Opening of the IP3Rs is regulated by a set of proteins present at or 
recruited to MAMs, including calnexin (CNX), the Sigma non-opioid 
intracellular receptor 1 (Sigma1R), presenilin 1 and 2 (PS1 and PS2). 
The presence of CNX at MAMs in turn is regulated by the sorting 
proteins Rab32 and phosphofurin acidic cluster protein 2 (PACS2), 
as well as by palmitoylation of CNX. The association of Sigma1R 
with MAMs on the other hand depends on cholesterol levels. Dys-
regulation of calcium signaling at MAMs is strongly implied in neu-
rodegenerative disorders. PS1 and PS2 play a complex role regulating 
both the extent of ER-mitochondrial contact and calcium signaling. 
The Parkinson’s disease (PD)-associated Parkin, DJ1 and α-synuclein 
(α-Syn) were also found to affect calcium transfer at these contacts. 
Finally, defects in mitofusin 2 (MFN2) or VAMP-associated protein 
B and C (VAPB), which contribute to the structural integrity of the 
MCSs, affect the calcium crosstalk between the ER and mitochondria
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a challenge, which is highlighted by the many diseases 
caused by defects in the proteins involved in mitochondrial 
dynamics [19] (see Boxes 2–4; Table 1). Mitochondrial fis-
sion is known to require the assembly of dynamin-related 
protein 1 (Drp1) in a helix around the OMM, followed 
by constriction of this ring (Fig. 5). However, it has long 
been unclear what signaling events precede this process 
and mark the site of Drp1 assembly. In 2011, Friedman 
et al. showed in Cos7 cells that focal accumulation of Drp1 
and subsequent fission occurs at or near sites of contact 
with the ER, and the same holds true for the yeast Drp1 
ortholog Dnm1 [37]. Mitochondrial constriction occurs in 
the vicinity of the ER even in the absence of Drp1 and the 
mitochondrial fission factor (Mff). These observations sug-
gested that ER tubules mark the sites of mitochondrial fis-
sion and induce initial constriction, followed by the recruit-
ment of Mff and finally Drp1 helix assembly that mediates 
the division [37]. Indeed, recent studies have described 
that actin polymerization, induced at the MCSs by an 
ER-bound isoform of Inverted Formin 2 (INF2), is capa-
ble and required to induce the initial constriction required 
for mitochondrial fission (Fig. 5) [58]. Spire1C, a newly 
described mitochondrial isoform of the actin-nucleating 
Spire proteins, interacts with INF2 to specifically nucleate 
actin filaments only at sites where the ER and mitochon-
drial membranes are closely apposed. Loss of this inter-
action results in long tubular mitochondria reminiscent of 
defective fission [70]. Mitochondrial constriction prior to 
Drp1 assembly depends on this actin polymerization step, 
however, additional force generated by Myosin II may also 
contribute to this process [30, 57]. How mutations in INF2, 
causing Charcot–Marie–Tooth disease type 2D and glomer-
ulopathy [15] affect this process remains to be determined. 
Finally, it was shown in a very elegant way that Drp1 activ-
ity at the MAMs is strictly regulated by phosphorylation in 
a process that involves Rab32 and syntaxin 17 (STX17) [4] 
(Fig. 5). This process seems tightly linked to the regulation 
of calcium homeostasis and the initiation of autophagy (see 
further). In addition, SUMOylation of Drp1 was reported 
to affect its function at the MAM, stabilizing the ER-mito-
chondria contact site and thus promoting calcium crosstalk 
and cytochrome c release [86].
Cytosol Mitochondrion
ER
PINK1
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STX17
Rab32
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Spire1C
Trak1/2
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MFN1/2  
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Kin/Dyn
Parkin
Fig. 5  MAMs control mitochondrial dynamics. Endoplasmic reticu-
lum (ER)-mitochondria contact sites are involved in mitochondrial 
fission and transport of mitochondria along cytoskeletal tracks. Dur-
ing fission, mitochondria-associated membranes (MAMs) determine 
the site of scission by contributing to the mitochondrial constriction 
required for dynamin-related protein 1 (Drp1) assembly. This con-
striction is accomplished through the actin-modulating activity of 
Spire1C and inverted forming 2 (INF2) at the membrane contact sites 
(MCSs). At least two other MAM proteins, syntaxin 17 (STX17) and 
Rab32, contribute to the regulation of mitochondrial fission by con-
trolling Drp1 activity. Mitochondrial transport is primarily mediated 
by the mitochondrial Rho GTPases 1 and 2 (Miro1/2), which con-
nect the mitochondria to motor proteins such as kinesins through the 
trafficking kinesin protein (TRAK) adaptor proteins. Miro depends 
on mitofusin1 and 2 (MFN1/2) to facilitate transport, and PTEN-
induced putative kinase 1 (PINK1)-Parkin-dependent ubiquitination 
of Miro1/2 and MFN2 blocks mitochondrial movement. In zones of 
high calcium concentrations, such as those that occur at MAMs, cal-
cium binding to the Miro1/2 EF-hand motifs releases the mitochon-
dria from the cytoskeleton and halts their migration. The P56S muta-
tion in VAMP-associated protein B and C (VAPB), which results in 
a higher degree of ER-mitochondria contact and calcium crosstalk, 
consequently results in axonal transport defects of mitochondria
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In contrast to the role of Gem1p in ER-associated mito-
chondrial division in yeast, no such role has been described 
for the mammalian Gem1 orthologs Miro1 and Miro2. In 
mammalian cells, both Miro proteins 1 and 2 are known as 
essential regulators of mitochondrial motility [36, 69, 92]. 
These atypical Rho GTPases are anchored in the OMM and 
mediate anterograde and retrograde transport by connect-
ing the mitochondria to microtubule (MT)-bound kinesin 
and dynein through the trafficking kinesin (TRAK1 and 
TRAK2) adaptor proteins (Fig. 5) [36, 69]. Neuron-specific 
loss of Miro1 in mice results in a neuronal disease pheno-
type that most closely resembles that of spastic paraplegia 
patients [80] (see Box 4; Table 1).
Interestingly, several observations point to a role of 
MAMs in Miro1/2-mediated cellular transport of mitochon-
dria. First, as mentioned, the yeast ortholog of Miro1/2 is a 
regulatory subunit of the ERMES complex and Miro1 local-
izes at ER-mitochondria contact sites in mammalian cells 
[56]. Second, at sites of close contact, the ER and mitochon-
dria move along acetylated MTs w hile staying attached, 
suggesting coordinated transport [38]. Third, in addition to 
coordinating fusion and tethering to the ER of the OMM, 
MFN2 is required for axonal transport and both MFN1 and 
MFN2 interact with Miro1/2 [75]. Fourth, mitochondrial 
transport is regulated by calcium through the EF-hand motifs 
in Miro1/2, which function as a calcium sensor. Calcium 
binding of Miro1/2 induces a conformational change that 
disconnects the mitochondria from the MT track it moves 
along, thus halting its transport [20, 69, 92]. Due to the rela-
tively low affinity of Miro1/2 to calcium, calcium-dependent 
halting of mitochondrial transport is most likely to occur at 
calcium hotspots, such as the ER-mitochondria MCSs [20, 
92]. The dependence on high calcium regions indicates a 
mechanism whereby the proximity with the ER can deter-
mine the redistribution of mitochondria. This provides the 
cell with a powerful system of targeting mitochondria based 
on local energy requirements. Particularly in neurons, this 
might be a relevant factor in determining the distribution 
of mitochondria to the dendrites, synapses and the nodes of 
Ranvier that is currently insufficiently understood. That such 
a system is essential for neuronal survival is underscored by 
the many reports of mitochondrial transport defects in neuro-
degenerative disorders [19]. Much research has focused on 
the connection between mitochondria and MTs in this con-
text. It is becoming increasingly clear, however, that the con-
nection with the ER is also a major determinant for axonal 
transport of mitochondria (see Boxes 2–4).
MAMs as a potential regulator of autophagy 
and mitophagy
Macroautophagy is the process whereby damaged proteins 
and organelles are cleared from the cell by sequestering 
them in a double membrane-bound vesicle termed the 
autophagosome. Subsequent delivery to the lysosome 
allows proteasomal breakdown and recycling of the sub-
strates. Debate is still ongoing with respect to the origin of 
the phagophore and the identity of membrane donor sources 
needed for its expansion to form the mature autophagosome 
[62]. Axe et al. identified the omegasome, a phosphatidylin-
ositol-3-phosphate-enriched membrane structure attached 
to the ER, as a membrane source for phagophore develop-
ment [8]. In addition, the mitochondria, harboring many 
autophagy-related (ATG) proteins and regulators thereof, 
have been proposed as an origin for phagophore formation, 
based on the transfer of a fluorescently labeled mitochon-
drial marker to the phagosome [43]. Intriguingly, several 
ATG proteins have been found to accumulate specifically 
at ER-mitochondria MCSs in conditions of starvation, 
and more and more evidence is accumulating that MAMs 
might be the actual site of autophagosome formation, uni-
fying both earlier models [43]. Hailey et al. first specu-
lated on the requirement of lipid transfer from the ER to 
mitochondria during autophagosome biogenesis. In mouse 
cells lacking MFN2, autophagy induction was disturbed. 
The authors contributed this to a decreased lipid transfer 
towards mitochondria as a consequence of ER-mitochon-
drial uncoupling and concluded that lipids transferred from 
the ER accumulate in the OMM, from where they are traf-
ficked to the expanding phagophore [43] (Fig. 6). A more 
direct involvement of MAMs in autophagosome biogen-
esis was proposed by Hamasaki and coworkers [44]. Upon 
starvation of mammalian cells, Vps15, Vps34, Atg14L, 
Beclin1—early markers of phagophore formation—and 
the omegasome marker double FYVE-containing protein 
1 (DFCP1) accumulate in the MAM fraction (Fig. 6) [44]. 
This might be initiated by early translocation of STX17 [4]. 
In starvation conditions, STX17 translocates in an mTOR/
ULK dependent manner to a domain of ER-mitochondrial 
contact resistant to digitonin, where it recruits ATG14L [4]. 
ATG14L then interacts with the phosphoinositide 3-kinase 
complex consisting of Beclin1, p150 and Vps34, resulting 
in local phosphatidylinositol-triphosphate production. This 
alters the local lipid composition of the MAM membrane, 
which leads to the recruitment of WD-repeat domain phos-
phoinositide interacting (WIPI) proteins, the effector pro-
teins and the mediators of autophagosome biogenesis. It 
has been proposed that this could be sufficient to induce a 
deformation of the membrane [62]. Consistent with a role 
for the MAMs in autophagosome formation, knockdown 
of MFN2 or PACS2 abolished ATG14L puncta formation 
and downstream LC3 lipidation in starved cells, and caused 
defective STX17 localization at the MAM [44].
In addition, during the selective autophagy of mitochon-
dria, known as mitophagy, ER-mitochondria contact sites 
appear to constitute a platform promoting mitophagosome 
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formation. In yeast, efficient mitophagy depends on cou-
pling of mitochondria and the ER through ERMES, while 
bulk autophagy can apparently operate in the absence 
of this tether [13]. ERMES colocalizes with sites of 
mitophagosome biogenesis and affects the formation of the 
phagophore that engulfs the mitochondria destined for deg-
radation [13, 71].
In mammalian cells, mitochondria destined for degra-
dation recruit the E3 ubiquitin ligase Parkin to the OMM 
through PTEN-induced putative kinase 1 (PINK1) kinase 
activity. Ubiquitination of Parkin substrates subsequently 
recruits the autophagy machinery [31]. ER-mitochondria 
MCSs are implied in this process in several ways. First, 
focal accumulation of DFCP1 along mitochondria labeled 
for degradation with exogenously expressed Parkin sug-
gests a role for the ER/MAM as a membrane source for 
the mitophagosome [115]. Second, Drp1-mediated fis-
sion, at least in part mediated by contacts with the ER 
[37], is suggested to promote mitophagy by breaking off 
pieces of mitochondria promoting their engulfment by the 
mitophagosome [105]. Lastly, depolarization of the IMM 
through calcium (over)loading could be involved in PINK1 
and Parkin translocation to the OMM, activating mitophagy 
[31, 53].
While the exact mechanisms governing autophagy 
induction and progression are not entirely clear, several 
lines of evidence point to an essential role of the ER-
mitochondria interface during this process. The presence 
at the MAMs of several important players in metabolism, 
such as mTORC2 [11], allows to speculate that ER-mito-
chondria MCSs could represent a site of crosstalk between 
sensors of the cells’ energetic needs and the early players 
in autophagy. Additionally, through interorganelle com-
munication, dysfunctional mitochondria may be sensed at 
the MAMs, followed by mitophagy induction and targeted 
removal of these unhealthy mitochondria. Future research 
is needed to study these mechanisms and how they are dis-
rupted in disease. Dysregulation of neuronal energy metab-
olism and mitochondrial homeostasis are important factors 
contributing to neurodegeneration [94]. This appears rel-
evant in particular for PD (see Box 3), however, autophagy 
is a process whose dysregulation is widely implied in neu-
rodegenerative disorders [73].
Conclusion
MCSs provide pathways of intracellular signaling that are 
only beginning to be unraveled. Although many questions 
remain as to how ER-mitochondria MCSs are maintained 
and regulated, it is clear that many different pathways inter-
twine at these signaling hubs. Whether all the different 
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Fig. 6  MAMs as sites for autophagosome biogenesis. Mitochon-
dria-associated membranes (MAMs) were identified as a membrane 
source for autophagosome biogenesis. In a first instance, phosphati-
dylethanolamine (PE) synthesis at MAMs was believed to be a cru-
cial lipid source for these emerging organelles. However, ER-mito-
chondria contact sites appear to play a more direct role. Syntaxin 17 
(STX17) at MAMs recruits early autophagosome markers including 
Atg14L, Vps15, Vps34 and Beclin1. In addition, the omegasome 
marker double FYVE-containing protein 1 (DFCP1) translocates to 
these sites upon autophagy induction. Underscoring the relevance of 
ER-mitochondria membrane contact sites (MCSs), loss of phospho-
furin acidic cluster sorting protein 2 (PACS2) or mitofusin 2 (MFN2) 
abrogates autophagosome biogenesis
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functions described here occur simultaneously at the same 
MCS, or whether specialized ER-mitochondria MCSs 
exist that mediate a subset of these processes is currently 
unclear. Gaining further insight into the protein tethers that 
connect both organelles will be crucial to shed more light 
on the regulation of MAM functions.
As these functions become uncovered, also the rele-
vance of ER-mitochondria contact sites in disease becomes 
apparent. Neuronal cells in particular appear to be very vul-
nerable to insults affecting the balance in ER-mitochondrial 
communication. Indeed, many of the processes that require 
these contact sites are implied in neurodegeneration. As 
such, resolving the role of MAMs in the pathomechanisms 
leading to these disorders may unify several of the previ-
ously identified defects that occur during neurodegenera-
tion, including imbalances in calcium or lipid signaling, 
mitochondrial dynamics and autophagy pathways. Since 
tipping the balance in either direction appears detrimental 
for neuronal survival, uncovering the different players that 
maintain this delicate equilibrium will be crucial to under-
stand the role that MCSs play in these disorders and pos-
sibly lead to novel strategies to reverse ER-mitochondrial 
homeostasis defects in patients.
Box 1: Alzheimers’s dementia
Aberrant cleavage of the amyloid precursor protein (APP) 
is the main hallmark of AD pathogenesis. Mutations in 
PS1 and PS2, components of the ɣ-secretase complex 
involved in APP processing, are major causes of familial 
AD (FAD) (Table 1). Consistent with their known associa-
tion with lipid rafts, PS1, PS2, APP and ɣ-secretase activ-
ity are enriched at MAMs [6]. Moreover, in cells deficient 
of MFN2, which showed diminished MAM function in 
terms of lipid metabolism, the enzymatic activity of the 
ɣ-secretase was reduced by approximately 50 %, show-
ing that APP processing relies on intact ER-mitochondria 
crosstalk [5]. Vice versa, MAM function also depends on 
PS1 and PS2. ER-mitochondria MCSs and MAM-depend-
ent lipid metabolism were shown to be upregulated in cells 
deficient of PS1 and PS2 as well as in cell models of both 
familial and sporadic AD (SAD) [5]. The complicated inter-
play between the ɣ-secretase constituents and activity and 
ER-mitochondrial crosstalk also extends to calcium signal-
ing. The PS1 and PS2 proteins were shown to interact with 
IP3Rs and FAD-associated mutations in either gene result 
in a higher IP3R gating activity and exaggerated calcium 
release from the ER, followed by increased APP cleavage 
[21, 22]. In turn, exposing hippocampal neurons or neu-
roblastoma cells to amyloid β enhances ER-mitochondria 
contact and calcium transfer [33, 47]. Post-mortem analy-
sis of human AD brain and those of AD mouse models 
showed altered expression levels of PACS2 and Sigma1R, 
MAM proteins involved in calcium handling, thus further 
establishing dysregulated MAM signaling as a hallmark of 
AD [47]. How exactly MAM function influences APP pro-
cessing and how a defect in the ɣ-secretase in turn affects 
ER-mitochondria MCSs remains to be further clarified. The 
finding that MAMs are involved early in the pathogenesis 
of both FAD and SAD is a major breakthrough nonetheless, 
as it can explain many of the different neuronal defects 
associated with AD, including calcium homeostasis, mito-
chondrial dysfunction, oxidative stress and lipid metabo-
lism [93]. Most recently, it was also reported that the E4 
allele of the apolipoprotein E (ApoE4), a major risk factor 
for developing SAD, contributes to increased crosstalk at 
the ER-mitochondria MCS [101]. MAMs are thus placed 
center-stage in the AD pathogenesis and therefore make for 
a promising target for therapeutics. One such target could 
be GSK3β, a central regulator of homeostasis in the brain 
that is implied in a large number of disorders including AD 
[66]. As further elaborated upon in BOX 2, GSK3β was 
recently identified as a negative regulator of ER-mitochon-
dria MCSs formation [97].
Box 2: Amyotrophic lateral sclerosis
MAM integrity and signaling have been found affected in 
several ALS subtypes. VAPB is an ER protein involved in 
tethering the MAM to mitochondria [29]. A point mutation 
in the gene encoding VAPB was identified in patients suf-
fering from the severe familial ALS type 8 [81] (Table 1). 
Mutant VAPB is enriched at the MAM, where increased 
binding with PTPIP51 tightens the connection at the ER-
mitochondria interface and results in higher mitochondrial 
calcium peaks (Fig. 4) [29]. More recently, two other pro-
teins involved in ALS have been identified as modulators 
of this interaction: glycogen synthase kinase-3β (GSK3β), 
established as a negative regulator of VAPB/PTPIP51 inter-
actions, and TAR DNA-binding protein 43 (TDP43), which 
activates GSK3β [97] (Figs. 2, 4). GSK3β hyperactivity is 
not only connected to ALS, but it also takes a central role 
in the disease mechanisms leading up to AD and PD, both 
in familial and sporadic cases [41, 66] (Table 1). TDP43 
accumulation on the other hand is a hallmark of the FTD/
ALS pathology and mutations in the TDP43 gene occur in 
approximately 3 % of patients with familial ALS as well 
as in 1.5 % of sporadic cases [63] (Table 1). Overexpres-
sion of TDP43 leads to an activation of GSK-3β and con-
sequently weakens ER-mitochondria coupling [97]. In a 
transgenic TDP43 mouse model for ALS, motor neurons 
show reduced contact between the ER and mitochondria. 
Similarly, overexpression of wild type or mutant TDP43 in 
NSC34 cells disrupts both the structural and the functional 
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connection between both organelles, ensued by a dimin-
ished exchange of calcium [97]. The fact that in one ALS 
subtype calcium signaling at MAMs is found to be upregu-
lated, whereas it appears downregulated in another, under-
scores the importance of balanced communication between 
both organelles for neuronal survival.
In addition to tightened contact between the ER and 
mitochondria and elevated calcium transfer, expression 
of VAPB P56S disrupts the connection of Miro1 to tubu-
lin, obstructing anterograde, but not retrograde mitochon-
drial transport in rat cortical neurons [77]. This phenotype 
was rescued by the co-expression of a calcium-insensitive 
Miro1 mutant, emphasizing the importance of controlled 
calcium signaling at MAMs for mitochondrial transport 
[77]. Of note, an earlier report showed that fibroblasts 
derived from VAPB P56S patients as well as neuronal 
cultures displayed intracellular aggregates containing 
VAPB and Sigma1R, a major regulator of calcium traf-
ficking at MAMs [46]. Moreover, pharmacological Sig-
ma1R activation was neuroprotective in this context and 
led to decreased VAPB aggregation [85]. Interestingly, 
mutations in the gene coding for Sigma1R are also asso-
ciated with ALS/FTD [2, 67]. A physiological connection 
between VAPB and Sigma1R at the MAMs remains to be 
determined, however, the defect in mitochondrial dynamics 
upon loss of Sigma1R points to a shared function of both 
proteins in ER-regulated axonal transport of mitochondria 
[9]. As the large majority of ALS cases are sporadic rather 
than familial, it will be crucial to study whether MAMs 
also play a role in these sporadic cases.
Box 3: Parkinson’s disease
Parkinson’s disease is caused by loss of dopaminergic 
neurons in the substantia nigra. A minority of PD cases 
are monogenic, caused by mutations in the genes encod-
ing Parkin, PINK1, alpha-Synuclein (α-Syn) or the protein 
deglycase DJ-1 amongst others [94]. Parkin and PINK1, as 
mentioned, play important roles in mitophagy and muta-
tions in the genes encoding these proteins are believed to 
disrupt the proper degradation of defective mitochondria 
[31]. The function of Parkin, however, appears broader than 
merely marking damaged mitochondria. In cultured rat 
neurons, glutamate excitotoxicity elicits the accumulation 
of Parkin at mitochondria, the ER and the ER-mitochon-
drial interface, without inducing mitophagy [107]. Overex-
pression of Parkin was previously shown to increase physi-
cal and functional coupling of the ER and mitochondria, 
stimulating ATP production and calcium exchange, while 
knockdown has the opposite effect and disrupts mitochon-
drial morphology [17]. The exact function of Parkin at the 
ER or its junctions with mitochondria and whether and how 
this is connected to its function in mitophagy is currently 
unclear, however, these observations point to a protective 
role for Parkin during excitotoxic stress, by maintaining 
ER-mitochondrial crosstalk.
Like Parkin, also α-Syn and DJ-1 overexpression pro-
motes MAM function and interaction with mitochon-
dria (Fig. 2) [18, 42, 82]. Intriguingly, all these proteins 
were reported to interact with Grp75, providing a plausi-
ble mechanism whereby they can affect ER-mitochondria 
calcium signaling, although alternative pathways may be 
involved as well [51]. Wild type α-Syn, known to have a 
high affinity for lipid rafts, localizes to MAMs where it 
promotes physical contact with mitochondria [18]. Con-
sistent with a role for α-Syn in contact formation, loss of 
α-Syn at the MAMs results in diminished ER-mitochondria 
signaling [18, 42]. In contrast to wild type α-Syn, PD-caus-
ing mutant forms of α-Syn downregulate ER-mitochondrial 
apposition, presumably through disrupted interaction with 
lipid rafts in the case of A30P mutant α-Syn, or through 
decreased levels of total α-Syn in the case of the A53T 
mutant [5, 35]. Accumulation of α-Syn in protein aggre-
gates termed Lewy bodies, a major hallmark of both famil-
ial and sporadic PD, could therefore represent of loss of 
function of this protein at the MAMs, which may underlie 
the disorder.
No direct involvement for PINK1 in ER-mitochondrial 
crosstalk has been reported. It does, however, play a role 
in mitochondrial motility, regulation of which also takes 
place at this interface. In addition to local calcium levels, 
mitochondrial motility is regulated through proteasomal 
breakdown of the transport complex, as PINK1 promotes 
the proteasomal degradation of Miro1/2 and MFN1/2 in 
a Parkin-dependent manner [65, 102, 113]. Intriguingly, 
loss of Miro was shown to rescue the phenotype caused by 
expression of PD-causing PINK1 mutations in Drosophila 
and facilitates clearance of damaged mitochondria in HeLa 
cells, suggesting that this process plays a significant role in 
the disease [65]. Further research is needed to investigate 
how contacts of mitochondria with the ER are involved in 
this pathway and whether ubiquitination of MFN2 by Par-
kin can modulate these contacts, as reported for MITOL 
[98]. Combined, these findings accentuate the complex 
interdependence of mitochondrial quality control and mito-
chondrial dynamics, pathways that clearly intersect at the 
ER-mitochondrial interface.
Box 4: Axonopathies
CMT and HSP are both caused by degeneration of long axons, 
in the case of CMT those of the peripheral motor and/or sen-
sory nerves, while the upper motor neurons are predominantly 
affected in the case of HSP. Unsurprisingly, these disorders 
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share many commonalities with regards to the pathomecha-
nisms involved and a disproportionate number of affected 
genes localizes to mitochondria, the ER, or the MCSs shared 
by both [103]. In HSP, membrane shaping of the ER is a major 
theme, with involved genes including Receptor Expression-
Enhancing Protein 1 and 2 (REEP1/2), Spastin, Reticulon 
2 (RTN2) and Atlastin 1 (ATL1). ATL1 and ATL3 are also 
found mutated in hereditary sensory and autonomous neurop-
athy (HSAN) [49, 54]. Work in yeast suggests that defects in 
ER-shaping proteins may affect ER-mitochondrial MCSs and 
lipid transfer. Interestingly, the RTN2 homolog RTN4b was 
identified as a negative regulator of crosstalk between both 
organelles [99]. More recently, HSP-causing mutations in or 
loss of REEP1 were also reported to disrupt ER-mitochondria 
MCSs [64]. Though no direct effect on MCSs was reported, 
neurons differentiated from patient-derived induced pluripo-
tent stem cells carrying the HSP-causing P342S mutation in 
ATL1 display not only defects in ER morphology, but also in 
the axonal transport of mitochondria [116]. Another exam-
ple of an ER-bound protein that modulates mitochondrial 
dynamics is INF2, mutations in which cause CMT associated 
with glomerulopathy [15]. INF2 modulates actin dynamics 
required for MAM-dependent mitochondrial fission (see main 
text and Fig. 5) [58, 70]. How CMT-causing mutations in this 
gene affect mitochondrial dynamics remains to be elucidated, 
however, it is clear that ER-resident proteins can play signifi-
cant roles in mitochondrial dynamics through the interface 
between both organelles. Similarly, proteins known for their 
role in mitochondrial dynamics can affect the ER network. 
CMT-causing mutations in MFN2 disrupt ER morphology 
and contact with mitochondria [28], in addition to interfering 
with mitochondrial dynamics and distribution within axons 
[75, 76]. Since these mutations do not affect the interaction of 
MFN2 with Miro1/2, aberrant connectivity with the ER might 
be the underlying factor causing mislocalization of mitochon-
dria within axons [76]. It is clear that the interplay between 
ER and mitochondrial network dynamics and interorganelle 
communication plays a pivotal role in axonal survival and 
degeneration. Though the exact mechanisms controlling mito-
chondrial motility at the MCSs with the ER are the subject of 
ongoing research, several observations suggest that a multi-
tude of pathways can impinge on this process and it is likely 
that the signaling hub where these pathways are integrated, are 
the ER-mitochondria contact sites.
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